Late Stage Investors & VC Firms in Netherlands

35 firms in this list, with a median first check of $1M. 2 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
BL Blue Horizon Corporation RLTKTGBW4 people	88🔒	Zurich	CH	Pre-Seed–Late Stage	—	+ Add to CRM
GE General Atlantic GCMEWEAP9 people · Leads rounds	88🔒	Stamford	US	Series B–Late Stage	$10M – $1B	+ Add to CRM
MO Motive Partners Leads rounds	88🔒	New York	US	Pre-Seed–Late Stage	$1M – $10M	+ Add to CRM
AT Atomico NZAHBBCB11 people	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
FO Fortino Capital DSFVIKJV11 people	88🔒	Antwerp	BE	Seed–Late Stage	$540K – $32.4M	+ Add to CRM
B2 b2venture FSAGCSGJ11 people	88🔒	Berlin	DE	Pre-Seed–Late Stage	$270K – $5.4M	+ Add to CRM
EQ EQT Life Sciences APFVFAJR11 people	88🔒	Amsterdam	NL	Seed–Late Stage	$10.8M – $64.8M	+ Add to CRM
EU European Circular Bioeconomy Fund DSMAMBMN11 people	88🔒	Bonn	DE	Growth–Late Stage	$2.7M – $10.8M	+ Add to CRM
FL Flashpoint Venture Capital AKAFDMIB11 people	88🔒	London	GB	Seed–Late Stage	$1M – $15M	+ Add to CRM
GI Gilde Healthcare AFEDGPHD11 people	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $32.4M	+ Add to CRM
IN Innovation Industries CSHDNSCG11 people	88🔒	Amsterdam	NL	Seed–Late Stage	$2.2M – $27M	+ Add to CRM
OO Oost NL BHBSFWHT11 people	88🔒	Apeldoorn	NL	Seed–Late Stage	$108K – $2.7M	+ Add to CRM
SM SmartFin BLJIHHST10 people	88🔒	Brussels	BE	Seed–Late Stage	$1.1M – $27M	+ Add to CRM
DS dsm-firmenich Venturing SHAKADAM9 people	88🔒	Maastricht	NL	Pre-Seed–Late Stage	$108K – $5.4M	+ Add to CRM
EU Eurazeo AACMESEL11 people	88🔒	Paris	FR	Series A–Late Stage	—	+ Add to CRM
TV TVM Capital HBLMMRSF8 people	88🔒	Munchen	DE	Seed–Late Stage	$1.1M – $16.2M	+ Add to CRM
DR DRW Venture Capital KT1 person	88🔒	Chicago	US	Seed–Late Stage	$1M – $5M	+ Add to CRM
FO Forbion CI1 person	88🔒	Amsterdam	NL	Pre-Seed–Late Stage	—	+ Add to CRM
CA Capital Mills BDEVGDRD6 people	88🔒	Gorinchem	NL	Series A–Late Stage	$270K – $2.7M	+ Add to CRM
AN Anterra Capital AAMGPABW8 people	88🔒	Amsterdam	NL	Seed–Late Stage	$20M	+ Add to CRM
CL Clay Capital MDMVGCKL5 people	88🔒	—	SG	Seed–Late Stage	$3M – $8M	+ Add to CRM
DE Debiopharm Innovation Fund MCTGVLCO5 people	88🔒	Lausanne	CH	Series A–Late Stage	$3M – $5M	+ Add to CRM
PH Phoenix Contact Innovation Ventures ARMBCFRD5 people	88🔒	Blomberg	DE	Seed–Late Stage	$108K – $2.7M	+ Add to CRM
LI Liberty Growth APBDDPJH4 people	88🔒	Denver	US	Series B–Late Stage	$5M – $10M	+ Add to CRM

Blue Horizon Corporation

ZurichPre-Seed–Late Stage

RLTKTGBW4 people

General Atlantic

StamfordSeries B–Late Stage$10M – $1B

GCMEWEAP9 people

Motive Partners

New YorkPre-Seed–Late Stage$1M – $10M

Atomico

LondonSeed–Late Stage

NZAHBBCB11 people

Fortino Capital

AntwerpSeed–Late Stage$540K – $32.4M

DSFVIKJV11 people

b2venture

BerlinPre-Seed–Late Stage$270K – $5.4M

FSAGCSGJ11 people

EQT Life Sciences

AmsterdamSeed–Late Stage$10.8M – $64.8M

APFVFAJR11 people

European Circular Bioeconomy Fund

BonnGrowth–Late Stage$2.7M – $10.8M

DSMAMBMN11 people

Flashpoint Venture Capital

LondonSeed–Late Stage$1M – $15M

AKAFDMIB11 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $32.4M

AFEDGPHD11 people

Innovation Industries

AmsterdamSeed–Late Stage$2.2M – $27M

CSHDNSCG11 people

Oost NL

ApeldoornSeed–Late Stage$108K – $2.7M

BHBSFWHT11 people

SmartFin

BrusselsSeed–Late Stage$1.1M – $27M

BLJIHHST10 people

dsm-firmenich Venturing

MaastrichtPre-Seed–Late Stage$108K – $5.4M

SHAKADAM9 people

Eurazeo

ParisSeries A–Late Stage

AACMESEL11 people

TVM Capital

MunchenSeed–Late Stage$1.1M – $16.2M

HBLMMRSF8 people

DRW Venture Capital

ChicagoSeed–Late Stage$1M – $5M

KT1 person

Forbion

AmsterdamPre-Seed–Late Stage

CI1 person

Capital Mills

GorinchemSeries A–Late Stage$270K – $2.7M

BDEVGDRD6 people

Anterra Capital

AmsterdamSeed–Late Stage$20M

AAMGPABW8 people

Clay Capital

Seed–Late Stage$3M – $8M

MDMVGCKL5 people

Debiopharm Innovation Fund

LausanneSeries A–Late Stage$3M – $5M

MCTGVLCO5 people

Phoenix Contact Innovation Ventures

BlombergSeed–Late Stage$108K – $2.7M

ARMBCFRD5 people

Liberty Growth

DenverSeries B–Late Stage$5M – $10M

APBDDPJH4 people

Data sourced from public filings and firms' own websites — see our methodology.